Efficacy and Safety of Crisaborole Ointment 2% in Chinese Patients Aged ≥ 2 Years with Mild to Moderate Atopic Dermatitis

• Main Authors: Lin Ma (Author), Xiaohua Tao (Author), Sujun Liu (Author), Hao Cheng (Author), Ruihua Fang (Author), Yan Zhao (Author), Amy Cha (Author), Gerardo A. Encinas (Author), Yangmei Zhou (Author), Yujie Deng (Author), Jianzhong Zhang (Author)
• Format: Book
• Published: Adis, Springer Healthcare, 2024-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Introduction Atopic dermatitis (AD) is a chronic immuno-inflammatory skin disease. Crisaborole ointment, 2%, is a nonsteroidal phosphodiesterase 4 inhibitor approved for the treatment of mild to moderate AD. This post hoc analysis assesses the efficacy and safety of crisaborole in Chinese p...